Content about INDIANAPOLIS

March 27, 2014

Indiana Governor Mike Pence earlier this week signed legislation designed to create a pathway for the substitution of interchangeable biologic medicines, according to published reports.

INDIANAPOLIS — Indiana Governor Mike Pence earlier this week signed legislation designed to create a pathway for the substitution of interchangeable biologic medicines, according to published reports. 

The bill allows a pharmacist to substitute an interchangeable biosimilar product for a prescribed biological product if certain conditions are met. It requires the board of pharmacy to maintain a website that lists the biosimilar biological products that are determined to be interchangeable. 

The specific conditions include: 

January 24, 2014

Giant Eagle is making a push into Indiana with a Market District concept and GetGo, a convenience store, planned just outside of Indianapolis, according to published reports.

PITTSBURGH — Giant Eagle is making a push into Indiana with a Market District concept and GetGo, a convenience store, planned just outside of Indianapolis. 

It will be the first Giant Eagle stores in the state, which are slated to open in 2015, and additional stores in the metro area might follow.

“We are thrilled to bring our Market District and GetGo concepts to Carmel and greater Indianapolis,” Giant Eagle CEO Laura Karet said in a statement. “We are also actively evaluating opportunities for additional locations.”

 

January 23, 2014

CCA Industries, whose portfolio of health and beauty products includes Plus+White toothpastes and teeth whiteners, Bikini Zone medicated topical and shave gels, Nutra Nail nail care treatments and Gel Perfect UV-free gel color, is restructuring its operations and entering a partnership with sales and marketing company the Emerson Group

EAST RUTHERFORD, N.J. — CCA Industries, whose portfolio of health and beauty products includes Plus+White toothpastes and teeth whiteners, Bikini Zone medicated topical and shave gels, Nutra Nail nail care treatments and Gel Perfect UV-free gel color, is restructuring its operations and entering a partnership with sales and marketing company the Emerson Group    

December 30, 2013

Giant Eagle is expected to expand into the Indianapolis market, the Indianapolis Business Journal reported earlier this month, citing local real estate brokers.

INDIANAPOLIS — Giant Eagle is expected to expand into the Indianapolis market, the Indianapolis Business Journal reported earlier this month, citing local real estate brokers. 

November 6, 2013

Many physicians in Asia say more information on managing Type 2 diabetes is needed, according to a new poll.

INDIANAPOLIS — Many physicians in Asia say more information on managing Type 2 diabetes is needed, according to a new poll.

October 1, 2013

Health insurer WellPoint said Tuesday that most of its affiliated Medicare drug plans and medical plans with drug coverage will participate in a preferred pharmacy network that includes Rite Aid, Kroger and Walmart pharmacies.

INDIANAPOLIS — Health insurer WellPoint said Tuesday that most of its affiliated Medicare drug plans and medical plans with drug coverage will participate in a preferred pharmacy network that includes Rite Aid, Kroger and Walmart pharmacies.

Together, WellPoint said, members had access to more than 11,000 locations around the country. The preferred pharmacy network is part of all of WellPoint's affiliated Part D standalone prescription drug plans and most of its Medicare Advantage Prescription Drug Plans.

August 22, 2013

Community Health Network has officially begun its clinical collaboration with the Healthcare Clinic, formerly Take Care Clinics, at select Walgreens creating one of the largest integrated continuums of healthcare delivery in Indiana.

INDIANAPOLIS — Community Health Network has officially begun its clinical collaboration with the Healthcare Clinic, formerly Take Care Clinics, at select Walgreens creating one of the largest integrated continuums of healthcare delivery in Indiana.

July 16, 2013

Men who took an erectile dysfunction drug made by Eli Lilly experienced normal erectile function when taking it once a day as opposed to taking erectile dysfunction treatment on an as-needed basis, according to a new study.

INDIANAPOLIS — Men who took an erectile dysfunction drug made by Eli Lilly experienced normal erectile function when taking it once a day as opposed to taking erectile dysfunction treatment on an as-needed basis, according to a new study.

The study, published in the Journal of Sexual Medicine, found a greater percentage of men who had an incomplete response to as-needed treatment with phosphodiesterase type 5, or PDE5 inhibitors, a drug class that includes Lilly's Cialis (tadalafil), compared with those who took Cialis once a day.

May 28, 2013

After 50 years of service with the company, Kroger's mid-south division president John Hackett is retiring.

LOUISVILLE, Ky. — After 50 years of service with the company, Kroger's mid-south division president John Hackett is retiring. Hackett began his career with Kroger in 1963 as a store clerk in London, Ohio, while working his way through college at The Ohio State University.

May 2, 2013

Drug makers Boehringer Ingelheim and Eli Lilly have started a campaign designed to educate healthcare professionals about the role a type of protein plays in maintaining blood-sugar balance.

INDIANAPOLIS — Drug makers Boehringer Ingelheim and Eli Lilly have started a campaign designed to educate healthcare professionals about the role a type of protein plays in maintaining blood-sugar balance.

BI and Lilly created the website sglt.com to inform users about the role of sodium glucose co-transporters. The program also includes a video, Glucose Perspectives, in the form of a sketch animation by the United Kingdom's Royal Society for the Encouragement of Arts, Manufactures and Commerce.

February 6, 2013

Adults living with diabetes in the United States reported highest satisfaction using Roche Diabetes Care's Accu-Chek products compared with other blood-glucose-meter manufacturers, according to the inaugural J.D. Power and Associates 2012 Blood Glucose Meter Satisfaction Study.

INDIANAPOLIS — Adults living with diabetes in the United States reported highest satisfaction using Roche Diabetes Care's Accu-Chek products compared with other blood-glucose-meter manufacturers, according to the inaugural J.D. Power and Associates 2012 Blood Glucose Meter Satisfaction Study released Tuesday. 

The study gathered responses from 2,681 current meter users with type 1 and 2 diabetes in the U.S. to determine customer satisfaction across six factors: performance; ease of use; design; features; cost of test strips; and training.

January 30, 2013

Walgreens' subsidiary Take Care Health Systems announced a clinical collaboration with Indianapolis-based Community Health Network that will facilitate more coordinated healthcare services and improve patient access to high-quality, convenient and affordable care throughout central Indiana.

DEERFIELD, Ill. — Walgreens' subsidiary Take Care Health Systems on Wednesday announced a clinical collaboration with Indianapolis-based Community Health Network that will facilitate more coordinated healthcare services and improve patient access to high-quality, convenient and affordable care throughout central Indiana.

January 29, 2013

Eli Lilly and Company reported that its fourth quarter revenue for the period ended Dec. 31 declined 1% to $6 billion because of its Zyprexa patent expiration. Full-year 2012 revenue declined 7% to $22.6 billion.

INDIANAPOLIS — Eli Lilly and Company on Tuesday reported that its fourth quarter revenue for the period ended Dec. 31 declined 1% to $6 billion because of its Zyprexa patent expiration. Full-year 2012 revenue declined 7% to $22.6 billion.

December 21, 2012

Though total same-store sales were down 8%, Walgreens Friday morning characterized a first quarter lifted by a steady influx of returning Express Scripts patients and driven by a steady stream of new Balance Rewards members.

DEERFIELD, Ill. — Though total same-store sales were down 8%, Walgreens Friday morning characterized a first quarter lifted by a steady influx of returning Express Scripts patients and driven by a steady stream of new Balance Rewards members. The Chicagotown retailer has signed 45 million Walgreens faithful since mid-September. "Today, we have the wind at our backs as we head into a new calendar year," Walgreens president and CEO Greg Wasson told analysts Friday morning.  

December 18, 2012

More than two-thirds of generic drugs carry safety warning labels different from those of their branded equivalents, according to a new study.

INDIANAPOLIS — More than two-thirds of generic drugs carry safety warning labels different from those of their branded equivalents, according to a new study.

December 6, 2012

Pharmacy benefit manager Catamaran Corp. has opened a new "Center of Excellence" in downtown Indianapolis, the company said Thursday.

LISLE, Ill. — Pharmacy benefit manager Catamaran Corp. has opened a new "Center of Excellence" in downtown Indianapolis, the company said Thursday.

Catamaran announced the opening of the 13,000-square-foot center, which it said will support the services it will provide under the $60 million, six-year Medicaid contract with the Indiana state government, signed in October.

November 2, 2012

Eli Lilly is spending $140 million to expand its insulin manufacturing plant in Indianapolis, the drug maker said.

INDIANAPOLIS – Eli Lilly is spending $140 million to expand its insulin manufacturing plant in Indianapolis, the drug maker said.

Lilly said it would expand the plant by 80,000 sq. ft., saying it represented one of the most significant investments in its U.S. manufacturing operations in the past decade. Construction is expected to start immediately, with completion planned for March 2014.

October 3, 2012

A drug marketed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly reduced blood sugar in elderly patients with Type 2 diabetes and in adults with diabetic nephropathy, according to results of three studies presented at a diabetes meeting in Berlin.

INDIANAPOLIS — A drug marketed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly reduced blood sugar in elderly patients with Type 2 diabetes and in adults with diabetic nephropathy, according to results of three studies presented at a diabetes meeting in Berlin.

September 25, 2012

How do you transform a drug store into something else? Something new. Something no one has ever seen before. And what would it look like? 


How do you transform a drug store into something else? Something new. Something no one has ever seen before. And what would it look like? 


To truly reinvent something, you have to be willing to let go of everything you’ve ever known or thought you knew about it; you need to erase all of the preconceptions and abandon the archetypes of what you think it is, what people told you it should be. You need to find the white space. 


September 14, 2012

Drug makers Boehringer Ingelheim and Eli Lilly have created a new online educational program for people with Type 2 diabetes.

INDIANAPOLIS — Drug makers Boehringer Ingelheim and Eli Lilly have created a new online educational program for people with Type 2 diabetes.

The companies, which have had a deal to develop drugs for diabetes since January 2011 and co-market the drugs Tradjenta (linagliptin) and Jentadueto (linagliptin and metformin), announced Thursday the creation of My Well Planner, a lifestyle-improvement program for adults with the disease.

September 10, 2012

Amyotrophic lateral sclerosis patients from Chagrin Falls, Ohio, and cystic fibrosis patients from Indianapolis took part in pre-game, on-field traditions at Fenway Park to celebration CVS/pharmacy's Advancing Medical Research fundraising campaign, which raised more than $5 million in five weeks.

WOONSOCKET, R.I. — Amyotrophic lateral sclerosis patients from Chagrin Falls, Ohio, and cystic fibrosis patients from Indianapolis took part in pre-game, on-field traditions at Fenway Park to celebration CVS/pharmacy's Advancing Medical Research fundraising campaign, which raised more than $5 million in five weeks.

August 7, 2012

A biotech drug made by Eli Lilly for osteoporosis appeared no more or less effective than a pharmaceutical drug available as a generic in treating women with related bone fractures, but was more effective in some other measures, according to results of a late-stage clinical trial released Tuesday.

INDIANAPOLIS — A biotech drug made by Eli Lilly for osteoporosis appeared no more or less effective than a pharmaceutical drug available as a generic in treating women with related bone fractures, but was more effective in some other measures, according to results of a late-stage clinical trial released Tuesday.

July 31, 2012

The Walgreens Health Guide has a pharmacy technician license and at least two years in medical training. While there is a station positioned in front of the pharmacy, the Health Guides more often are in the aisles helping patients rather than waiting for patients to come to them.

The Walgreens Health Guide has a pharmacy technician license and at least two years in medical training. While there is a station positioned in front of the pharmacy, the Health Guides more often are in the aisles helping patients rather than waiting for patients to come to them. “Right now, more people are taking care of their own health than ever before, and they’re looking for a location that is convenient, that is professional, that is affordable,” noted Marcel Naddaf, Walgreens market pharmacy director for the Indianapolis and St.

July 19, 2012

Roche on Wednesday announced that it has received clearance from the Food and Drug Administration for its Accu-Chek Combo system for insulin pump therapy.

INDIANAPOLIS — Roche on Wednesday announced that it has received clearance from the Food and Drug Administration for its Accu-Chek Combo system for insulin pump therapy.

July 12, 2012

A clinical trial of a drug for schizophrenia did not yield the desired results, the drug's developer said.

INDIANAPOLIS — A clinical trial of a drug for schizophrenia did not yield the desired results, the drug's developer said.

Eli Lilly announced results of the H8Y-MC-HBBM study of pomaglumetad methionil, for patients with acute exacerbation of schizophrenia. The company said results did not show the drug produced a significantly different effect from the placebo.